open access

Vol 71, No 3 (2020)
Clinical vignette
Submitted: 2020-03-15
Accepted: 2020-03-17
Early publication date: 2020-05-12
Get Citation

Does metabolically healthy obesity exist? A 32-year-old man with BMI 78 kg/m2 — to treat or not to treat?

Marta Walczak-Gałęzewska1, Agnieszka Ratajczak2, Katarzyna Pastusiak2, Wiesław Bryl1, Paweł Bogdański2
DOI: 10.5603/EP.a2020.0022
·
Pubmed: 33140381
·
Endokrynol Pol 2020;71(3):281-282.
Affiliations
  1. Chair and Department of Internal Medicine, Metabolic Disorders, and Hypertension, Poznań University of Medical Sciences, Poznań, Poland
  2. Chair and Department of Treatment of Obesity, Metabolic Disorders, and Clinical Dietetics, Poznań University of Medical Sciences, Poznań, Poland

open access

Vol 71, No 3 (2020)
Clinical Vignette
Submitted: 2020-03-15
Accepted: 2020-03-17
Early publication date: 2020-05-12

Abstract

Not required for Clinical Vignette.

Abstract

Not required for Clinical Vignette.

Get Citation

Keywords

metabolically healthy; sever obesity

About this article
Title

Does metabolically healthy obesity exist? A 32-year-old man with BMI 78 kg/m2 — to treat or not to treat?

Journal

Endokrynologia Polska

Issue

Vol 71, No 3 (2020)

Article type

Clinical vignette

Pages

281-282

Early publication date

2020-05-12

Page views

579

Article views/downloads

500

DOI

10.5603/EP.a2020.0022

Pubmed

33140381

Bibliographic record

Endokrynol Pol 2020;71(3):281-282.

Keywords

metabolically healthy
sever obesity

Authors

Marta Walczak-Gałęzewska
Agnieszka Ratajczak
Katarzyna Pastusiak
Wiesław Bryl
Paweł Bogdański

References (4)
  1. Lauby-Secretan B, Scoccianti C, Loomis D, et al. International Agency for Research on Cancer Handbook Working Group. Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med. 2016; 375(8): 794–798.
  2. Alam I, Ng TP, Larbi A. Does inflammation determine whether obesity is metabolically healthy or unhealthy? The aging perspective. Mediators Inflamm. 2012; 2012: 456456.
  3. Hashimoto Y, Tanaka M, Okada H, et al. Metabolically healthy obesity and risk of incident CKD. Clin J Am Soc Nephrol. 2015; 10(4): 578–583.
  4. Maliszewska K, Adamska-Patruno E, Krętowski A. The interplay between muscle mass decline, obesity, and type 2 diabetes. Pol Arch Intern Med. 2019; 129(11): 809–816.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl